Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Farhat Nasim

Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Farhat Nasim

Articles By : Farhat Nasim

Indoco Remedies secures USFDA approval for Allopurinol Tablets to lower high uric acid levels in blood

Indian Pharma Market grows at 6.8 percent in October, Chronic Therapies Dominate: IQVIA

Farhat Nasim19 Nov 2024 6:19 PM IST

New Delhi: The Indian Pharmaceutical Market (IPM) experienced a significant 6.8% increase in Total Sales Audit (TSA) over the 12-month period ending...

Zydus Asked to Revise Phase III Trial Protocol for Cough Syrup FDC After CDSCO Panel Review

Delhi HC Grants Relief to Zydus in BIOCHEM Trademark Dispute

Farhat Nasim18 Nov 2024 3:28 PM IST

New Delhi: In relief to Zydus Healthcare, the Delhi High Court has granted an injunction restraining Alder Biochem Pvt. Ltd. from using the trademark...

Zydus barred from selling cancer drug Sigrima as Delhi HC restores injunction in favour of Roche

Farhat Nasim16 Nov 2024 3:25 PM IST

New Delhi: Upholding the patent rights of Swiss pharmaceutical giant F-Hoffmann-La Roche AG, the Delhi High Court has once again reinstated an...

Himachal to develop medical device park independently

DoP Releases Rs 500 Crore Operational Guidelines for Strengthening of Medical Device Industry Scheme

Farhat Nasim15 Nov 2024 5:54 PM IST

New Delhi: The Department of Pharmaceuticals (DoP) has released the operational guidelines for the newly launched Strengthening of Medical Device...

UPDGME Notifies On Scholarships for MD, MS Programs at Rajshree Medical Research Institute.

PMSPPS Scholarship: PCI to Award Rs 12,400 per month to Eligible GPAT Candidates for 2023-2025

Farhat Nasim15 Nov 2024 5:52 PM IST

New Delhi: The Pharmacy Council of India (PCI) has announced the disbursement of the Pradhan Mantri Scholarship for Pharmacy Post Graduate Studies...

Investigation Lapses Lead to Acquittal in Hospital Voyeurism Case

Misuse of Confidential Drug Dossiers for Losartan, Citalopram, Amlodipine: Noida Court Upholds Jubilant Generics' Injunction Against Rivals

Farhat Nasim14 Nov 2024 4:38 PM IST

Noida: A commercial court in Noida has upheld the injunction in favor of Jubilant Generics, preventing companies from manufacturing and supplying...

Dr Reddy's Hit with Rs 27 Lakh Fine in Mexico

Farhat Nasim14 Nov 2024 4:26 PM IST

New Delhi: Hyderabad-based pharmaceutical giant, Dr Reddy’s Laboratories, has been fined approximately Rs 27 lakh by Mexico’s regulatory body,...

Health Ministry notifies rules for recruitment of medical device officers in CDSCO, Industry body flags concerns

Farhat Nasim12 Nov 2024 11:22 PM IST

New Delhi: Through a recent Gazette notification, the Ministry of Health and Family Welfare has issued recruitment rules for various key positions in...

Dr Reddys Secures CDSCO Panel Approval to Import, Market Olutasidenib for AML

Two Dr Reddy's former employees ordered to repay Rs 41L, Rs 39L VRS amounts for reemployment

Farhat Nasim12 Nov 2024 5:16 PM IST

Hyderabad: Two former employees of Dr Reddy's Laboratories Limited (Dr Reddys) have been directed by the Labour Court-2 in Hyderabad to repay the VRS...

Mankind Pharma Gets CDSCO Panel Nod to Conduct Phase III Trial of Resmetirom Tablets

Delhi HC Grants Interim Relief to Mankind, Restrains AquaKind Labs from Using 'KIND' in Trademark

Farhat Nasim11 Nov 2024 6:51 PM IST

New Delhi: In relief to Mankind Pharma, the Delhi High Court has granted an ex-parte interim injunction restraining AquaKind Labs LLP from using the...

aristo pharma multivitamin tablets price

DoP Dismisses Aristo Pharma's Plea to Reassess Multivitamin Tablet Pricing Set by NPPA

Farhat Nasim10 Nov 2024 1:30 PM IST

New Delhi: The Department of Pharmaceuticals (DoP) recently rejected Aristo Pharmaceuticals' application challenging the price set for its...

Bristol Myers Squibb, SystImmune gets USFDA Breakthrough Therapy Designation for izalontamab brengitecan for previously treated Advanced EGFR Mutated Non Small Cell Lung Cancer

Delhi HC upholds Bristol Myers' patent for anti-cancer drug Dasatinib, imposes Rs 5L penalty on SP Labs

Farhat Nasim9 Nov 2024 5:40 PM IST

New Delhi: In relief to Bristol-Myers Squibb Holdings Ireland (BMS), the Delhi High Court has upheld its patent for the anti-cancer drug dasatinib and...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok